NeoGenomics - 48 Year Dividend Yield History | NEO

Historical dividend payout and yield for NeoGenomics (NEO) since 1971. The current TTM dividend payout for NeoGenomics (NEO) as of March 22, 2019 is $0.00. The current dividend yield for NeoGenomics as of March 22, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.774B $0.277B
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.179B 12.96
Gilead Sciences (GILD) United States $81.339B 10.35
Bio-Techne Corp (TECH) United States $7.264B 48.94